Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Zeo ScientifiX, Inc. reported a working capital deficit of $1,915,000 as of October 31, 2025, which improved to a positive $65,000 by June 30, 2026. The company remains dependent on external investment capital to fund operations and faces significant risks regarding supply chain stability and its ability to continue as a going concern.
OKMIN RESOURCES, INC. is an early-stage exploration company with no proven oil and gas reserves and limited capital, necessitating future equity raises to fund operations. The company faces significant operational risks as a non-operator and is highly sensitive to volatile commodity prices, which recently spiked over $100 per barrel due to Middle East conflicts.
Escalon Medical Corp. reported a significant increase in net income to $4,012,626 for the fiscal year ended June 30, 2026, primarily driven by a $2,813,525 gain from the sale of AXIS software and a $1,139,449 income tax benefit. Total revenues grew slightly to $12.7 million, while the company strengthened its cash position to over $3 million by year-end.
BAB, Inc. reported a net income of $533,428 for the nine months ended August 31, 2026, an increase from $438,188 in the prior year period. Total revenues grew to $2.44 million, driven by higher royalty and marketing fund revenues, while the company maintained a strong cash position of $2.75 million.
MedWellAI, Inc. reported a net loss of $1,589,465 for the fiscal year ended June 30, 2026, an improvement from a $3,607,145 loss in 2025 as it transitioned from digital asset mining to the health and wellness industry. The company faces significant liquidity challenges with a stockholders' deficit of $7,979,411 and an accumulated deficit of over $90 million, leading to a substantial doubt about its ability to continue as a going concern.
Anvi Global Holdings, Inc. reported a net loss of $110,707 for the six months ended August 31, 2026, compared to a loss of $105,270 in the prior year period. The company remains in a significant stockholders' deficit of $2,471,606 and is currently funded through advances from an officer to cover its general and administrative expenses.
Yan Chuang Group Inc. is a development-stage fintech company that has generated no revenue to date and reported a net loss of $75,448 for the fiscal year ended June 30, 2026. The company's auditors have issued a going concern warning due to its accumulated deficit of $104,215 and dependence on successful fundraising through its initial public offering.
Cybriatech Inc. reported a small net income of $598 for the nine months ended August 31, 2026, compared to a net loss of $24,009 in the prior year period. Despite the marginal profit, the company maintains an accumulated deficit of $30,211 and management expressed substantial doubt about its ability to continue as a going concern without additional investment capital.
National Rural Utilities Cooperative Finance Corp (CFC) is a tax-exempt cooperative providing financing to rural electric and telecommunication systems. For the period ending August 31, 2026, the company continues to fund operations through debt issuances and member investments, focusing on cost-based financial products rather than profit maximization.
Art’s-Way Manufacturing reported net income of $230,200 for the nine months ended August 31, 2026, a significant decrease from $1,680,423 in the prior year period despite a 12.3% increase in total sales. The decline in profitability was driven by higher cost of goods sold, increased operating expenses, and the absence of a large one-time 'Other' income gain recorded in 2025.
US Nuclear Corp. reported a net loss of $187,086 for the quarter ended March 31, 2026, an improvement from a $560,232 loss in the prior year. Revenue decreased to $352,209 from $476,705, while the company continues to face going concern risks with an accumulated deficit of over $21.4 million.
Citigroup reported Q3 2026 net income of $5.2 billion ($2.85 per diluted share) on revenues of $23.8 billion, an 8% increase year-over-year. The results were driven by growth in Services, Wealth, Markets, and Banking, alongside lower operating expenses. The company returned $4.1 billion to shareholders through common share repurchases and dividends during the quarter.
Term
Q3 2026
“Our performance in the quarter, which included the best third-quarter revenue in a decade, positive operating leverage and meaningful improvement in our returns, reflects the continued disciplined and consistent execution of our strategy.”
Jane Fraser, Citi Chair and CEO
“We returned over $4 billion to common shareholders while continuing to invest in growth and prepare for an AI-driven future. We expect to exceed this year's return target, even as we pull forward investments toward our 11-13% near-term goal —the next waypoints on our path to sustainable returns of 14-15%”
MADE IN USA INC. reported a net loss of $4,724 for the six months ended August 31, 2026, as the company transitions its business model toward blockchain and AI-based supply chain validation. A significant asset acquisition occurred during the period, with the issuance of 5,000,000 shares for $25,000,000 in intangible technology assets.
JPMorgan Chase reported Q3 2026 net income of $15.3 billion and earnings per share of $5.57 on managed revenue of $50.9 billion. The results were driven by a 13% year-over-year increase in net interest income and strong performance in Equity Markets, partially offset by higher compensation and technology expenses.
Wenyuan Group Corp. reported zero revenue for the three and six months ended June 30, 2026, resulting in a net loss of $116,090 for the first half of the year. The company's stockholders' deficit increased to $129,698 as of June 30, 2026, compared to $12,068 at the end of 2025, primarily due to ongoing operating expenses and a lack of sales.
Birdie Win Corp reported a net loss of $27,474 for the fiscal year ended July 31, 2026, on revenues of $20,000, which decreased from $30,000 in 2025. The company faces substantial doubt about its ability to continue as a going concern due to a working capital deficit of $13,104 and an accumulated deficit of $102,669.
Johnson & Johnson reported Q3 2026 sales growth of 5.9% to $25.4 billion, driven by strong performance in its Innovative Medicine and MedTech segments. The company raised its full-year 2026 guidance for both sales and adjusted EPS, despite a GAAP earnings impact from a one-time special charge related to talc litigation and recent M&A activity.
Term
Q3 2026
“Johnson & Johnson’s strong third-quarter performance and increased sequential growth reflect the accelerating momentum of our focused portfolio.”
Joaquin Duato, Chairman and Chief Executive Officer
“This progress, together with strategic investments in high-growth areas, gives us clearer line of sight to double-digit growth by the end of the decade.”
Joaquin Duato, Chairman and Chief Executive Officer
The Goldman Sachs Group, Inc. reported its financial results for the third quarter ended September 30, 2026. The company also scheduled a conference call to discuss the results and its future outlook, providing a formal presentation deck as part of the disclosure.
Albertsons Companies reported second quarter fiscal 2026 net sales of $18.9 billion and net income of $52 million, or $0.11 per share. The company saw an 11% increase in digital sales but an 0.8% decrease in identical sales, leading management to launch a comprehensive business review to simplify the organization and reduce costs.
Term
Q2 2026
“Although our second quarter performance was in-line with the expectations in our revised outlook, our results do not reflect the potential of the Company. We are launching a comprehensive business review to speed up improvements in Albertsons' performance and tackle even harder a cost structure we can no longer afford. Our work will find opportunities to simplify the organization, improve decision-making, reinvest savings in customer value, and boost long-term shareholder returns.”
Norris Industries, Inc. reported a net loss of $403,621 for the six months ended August 31, 2026, compared to a loss of $319,297 in the prior year period. The company faces liquidity challenges with a stockholders' deficit of $5.25 million, though it maintains a $600,000 credit line with a related party to fund ongoing oil and gas operations in Texas.
Wells Fargo reported third quarter 2026 net income of $6.0 billion, or $1.87 per diluted share, on total revenue of $21.87 billion. The results were driven by broad-based growth across operating segments, including a 12% revenue increase in Wealth and Investment Management and an 11% increase in both average loans and deposits. The company also repurchased $2.5 billion of common stock during the quarter.
Term
Q3 2026
“Our third quarter results reflect broad-based growth, higher earnings, and stronger returns. Diluted earnings per share increased to $1.87 in the third quarter, up 13% from a year ago. Our ROTCE increased from 14.7% during the first nine months of 2025 to 16.2% during the same period this year and 16.3% in the third quarter. Both average loans and average deposits increased 11% from a year ago.”
Charlie Scharf, Chairman and Chief Executive Officer
“While economic uncertainty exists and consumer sentiment remains mixed, our data shows that our consumer and business customers are doing well. Consumers are spending more, loan delinquencies are low, and deposit and investment balances have grown. Businesses continue to have strong balance sheets and losses remain low. While higher interest rates, higher oil prices and persistent inflation create risks to the economy, strong positive forces such as the investment in AI infrastructure, high employment levels and consistent wage growth continue to outweigh the risks”
Charlie Scharf, Chairman and Chief Executive Officer
Nurix Therapeutics reported a significant swing to profitability for the quarter ended August 31, 2026, with net income of $549.8 million compared to a net loss of $86.4 million in the prior year, primarily driven by $653.2 million in license revenue. The company's cash position strengthened significantly to $720.2 million, up from $247.0 million at the end of fiscal 2025.
Nurix Therapeutics reported financial results for its fiscal third quarter ended August 31, 2026, highlighting a cash position of $1.1 billion following a $700 million upfront payment from its Roche collaboration. The company achieved several clinical milestones, including dosing the first patient in its Phase 3 DAYBreak CLL-306 trial and advancing its STAT6 degrader into Phase 1 with Sanofi.
Term
Q3 2026
“The third quarter marked an important transition for Nurix as we moved bexobrutideg into Phase 3 development in CLL and began executing a broader clinical strategy designed to realize its potential across lines of therapy in both oncology and auto-immune disease.”
Arthur T. Sands, M.D., Ph.D., president and chief executive officer
OZ VISION INC. reported revenues of $46,930 and a net loss of $58,671 for the fiscal year ended June 30, 2026. The company faces significant liquidity challenges with only $4,388 in cash, leading to a going concern warning from its auditors.
FB Financial Corp reported third quarter 2026 net income of $60.2 million, or $1.20 per diluted share, driven by organic loan and deposit growth. Loans held for investment grew at an annualized rate of 9.68% to $13.18 billion, while total deposits increased to $14.67 billion. The company also highlighted a recent $125 million subordinated debt issuance to support future growth flexibility.
Term
Q3 2026
“Our results reflect continued organic growth momentum and solid profitability metrics. Annualized loan growth (HFI) was 9.68% for the quarter, annualized client deposit growth was 11.0%, and annualized total deposit growth was 8.82% when we net out the decline in brokered deposits. We are encouraged by the quality of opportunities in front of us and the pipelines we see across the Company. In addition, our recent $125.0 million subordinated debt issuance provides added flexibility to support future growth. We remain focused on providing value to clients and creating long-term value for our shareholders.”
Christopher T. Holmes, President and Chief Executive Officer
UnitedHealth Group reported third quarter 2026 revenues of $112.7 billion and adjusted earnings of $4.69 per share. The company raised its full-year 2026 adjusted earnings outlook to at least $20.50 per share, citing strong medical cost management and operational discipline.
Term
Q3 2026
“Our third quarter results reflect the discipline and execution our teams are bringing to every part of our business, as we continue evolving UnitedHealth Group to deliver a simpler, more supportive experience for patients and the clinicians who care for them.”
Stephen Hemsley, chief executive officer of UnitedHealth Group
Unity Bancorp reported Q3 2026 net income of $17.4 million, or $1.70 per diluted share, driven by robust loan and deposit growth and a $2.5 million tax benefit from investment tax credits. Net interest income rose to $34.3 million as the net interest margin expanded to 4.67%.
Term
Q3 2026
“We are pleased to report another strong quarter for Unity, highlighted by net income of $17.4 million, or $1.70 per diluted share, and continued momentum across our core banking franchise. Loan and deposit growth remained robust, net interest income increased, net interest margin expanded, and asset quality improved meaningfully during the quarter.”
James A. Hughes, CEO
“Looking ahead, we are confident in Unity's long-term prospects as we prepare for the planned leadership transition next year to our President, George Boyan. Mr. Boyan has been deeply involved in every aspect of our strategic and operational execution, and I am confident that Unity is well-positioned for continued success under his leadership.”
Domino’s Pizza, Inc. reported total revenues of $1.19 billion for the third quarter of 2026, a 3.4% increase over the prior year, driven primarily by supply chain growth. Net income rose to $152.2 million, or $4.60 per diluted share, while the company's balance sheet reflects a significant shift in debt classification with $1.33 billion moved to current liabilities.
Domino’s Pizza reported third quarter 2026 financial results, featuring global retail sales growth of 3.2% and the addition of 175 net new stores globally. U.S. same-store sales grew 0.3% while income from operations increased 8.3% compared to the prior year period. This quarter marked the first results under new CEO Joe Jordan, who emphasized a focus on franchisee profitability and market share gains.
Term
Q3 2026
“As I step into the CEO role, I am honored to lead Domino’s and build on the competitive advantages that have long set us apart: our iconic brand, best-in-class franchise system, global scale and proven operating capabilities. Our opportunity now is to capitalize on those strengths by getting even closer to our customers, helping our franchisees grow their profitability and turning our best performance into our everyday performance. By advancing winning ideas faster and executing them with greater clarity, speed and consistency, we can earn more occasions, continue gaining market share and create meaningful long-term value for shareholders. Domino’s has always been at its best when we are a step ahead. That mindset has helped us set the pace for the industry before, and it’s how we’ll push ourselves to do it again. I believe our next chapter will be our strongest yet.”
Zhanling International Ltd reported a net loss of $6,597 for the three months ended August 31, 2026, compared to a loss of $8,126 in the prior year period. The company remains a shell entity with no revenue, an accumulated deficit of $475,150, and is currently seeking a merger or acquisition target.